Clinical Trial Update: Saphenous Vein Allografts for Coronary Bypass

View source ↗

Summary

The trial evaluating cryopreserved saphenous vein allografts for coronary bypass grafting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Occlusion

Drugs mentioned

• Saphenous Vein Allograft

Snippet

Sponsor: CryoLife, Inc. | Conditions: Coronary Artery Disease, Occlusion of Artery | Status: COMPLETED